Predictors of Lactogenesis II

Status Completed

Clinical Trial Summary

The purpose of this study is to investigate what proportion of obese women will have a self-reported delay in lactogenesis II ("breastmilk coming in") compared to women with a normal weight. We hypothesize that obese women will have an absolute 20% increase in delayed lactogenesis II.

We will compare two group of women for delayed lactogenesis II, one group with obese women (BMI>30) and one group of women with a normal weight (BMI<30).

The secondary objective is to assess what other factors influence the self-reported delayed lactogenesis II.

Clinical Trial Description

Lactogenesis I occurs during pregnancy (midpregnancy and beyond), when the mammary glands becomes sufficiently differentiated to secrete small quantities of specific milk components. Lactogenesis II is defined as the onset of plentiful milk secretion and typically occurs between 30-40 hours post delivery. It is typically described by women as a sense of fullness and leakage of milk which is subjectively reported between 50-73 hours post delivery. The incidence of delayed lactogenesis II ranges from 17-44%.

The risk of neonatal weight loss is up to 7 times greater for exclusively breastfed infants of women who experience delayed lactogenesis II as compared to women who experience typical onset lactogenesisII. In a qualitative study of 114 lactating women, increasing BMI was significantly associated with maternal perceptions of delayed onset of lactogenesis II.

The United States Breastfeeding Committee supports exclusive breastfeeding for the first 6 months of life because it "may exert a small but positive influence in reducing the risk of obesity in childhood and later in life…" Breastfeeding has also been associated with decreased risk of maternal morbidities such as type 2 diabetes, subclinical cardiovascular disease and less abdominal visceral adiposity. Given that prolonged breastfeeding improves the overall health of the mother infant dyad, it is critical to obtain a better understanding of those factors predictive of successful breastfeeding outcomes.

At University of South Florida our clinics serve an ethnically diverse population which would benefit from directed efforts at improving breastfeeding. Before we can undertake such a plan we need to assess the contemporary factors impacting lactogenesis.

We plan to prospectively enroll 186 pregnant women into a protocol to examine factors associated with delayed lactogenesis. Ninety-three women will have a BMI of 30 or higher at the time of delivery and the other 93 women will have a BMI ≤ 29 at the time of delivery. ;

Study Design

Related Conditions & MeSH terms

Breastfeeding

Clinical Trial Details

NCT number	NCT02220413
Study type	Observational
Source	University of South Florida
Contact
Status	Completed
Phase
Start date	August 2014
Completion date	January 1, 2017

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00579605` - Motivational Interviewing to Promote Sustained Breastfeeding	N/A
Completed	`NCT05655364` - Development of a Breastfeeding Supportive Mobile Application	N/A
Completed	`NCT03853850` - Using Mobile Phone Text Messaging System to Improve Exclusive Breastfeeding Rate in a Resource-poor Caribbean Island	N/A
Completed	`NCT03957941` - FamilyLink and Breastfeeding	N/A
Withdrawn	`NCT03709004` - Pacifiers and Breastfeeding Among Mothers at Risk for Postpartum Depression	N/A
Completed	`NCT02958475` - Mother's Milk Messaging: Evaluation of a Bilingual Application (APP) to Support Initiation and Exclusive Breastfeeding in New Mothers	N/A
Active, not recruiting	`NCT05503069` - Community Interventions to Improve Breastfeeding	N/A
Not yet recruiting	`NCT02233439` - Double-blind, Placebocontrolled A Randomized Trial on the Efficacy of Herbal Galactogogues	N/A
Completed	`NCT01893736` - Professional Breastfeeding Support Intervention	N/A
Completed	`NCT02738957` - Effect of Prenatal Counseling on Breastfeeding Rates in Twins	N/A
Completed	`NCT00527956` - Facilitation and Barriers to Breastfeeding in the NICU	N/A
Completed	`NCT03655314` - Using the Electronic Health Record to Guide Management of Newborn Weight Loss	N/A
Completed	`NCT05562245` - Motivational Interviewing-Based Breastfeeding Education	N/A
Completed	`NCT05106634` - Evaluation of Breastfeeding Success and Self-Efficacy in Mothers Giving Birth Via Vaginal Delivery or Cesarean Section
Completed	`NCT05992753` - Mothers' Breast Milk Expression Experiences, Infant Feeding Attitudes and Perceived Social Support Levels
Recruiting	`NCT05213975` - Kinesio Taping Application After Cesarean Section	N/A
Recruiting	`NCT05250219` - Microchimeric Cell Tranfer From Mother to Child - Pilo Study
Recruiting	`NCT05371106` - Mycotoxins in Mothers Milk in Israel
Completed	`NCT03332108` - Novel Approach To Improving Lactation Support With Mobile Health Technology	N/A
Completed	`NCT02901665` - Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.